ArticleStem cell research & therapy2019

Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.

Jérôme Caron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.